Zobrazeno 1 - 10
of 204
pro vyhledávání: '"D. Fennelly"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
É. J. Ryan, B. Creavin, Y. L. Khaw, M. E. Kelly, H. M. Mohan, R. Geraghty, E. J. Ryan, R. Kennelly, A. Hanly, S. T. Martin, D. Fennelly, R. McDermott, D. Gibbons, P. R O'Connell, K. Sheahan, D. C. Winter
Publikováno v:
BJS Open. 2:456-463
Background Caudal-related homeobox transcription factor 2 (CDX2) is an intestine-specific transcription factor implicated in tumour differentiation, proliferation, cell adhesion and migration. Negative CDX2 status (CDX2-) is associated with worse pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552f6f80b0bec1e0181ee7b4260e94d9
https://doi.org/10.1002/bjs5.91
https://doi.org/10.1002/bjs5.91
Autor:
F. Sclafani, P. R. O'Connell, Robert Geraghty, Ishwarya Balasubramanian, David Gibbons, Helen Mohan, D. P. O’Donoghue, Rory Kennelly, S. T. Martin, Éanna J Ryan, John Hyland, Ray McDermott, Elizabeth J. Ryan, D Fennelly, Des C. Winter, Kieran Sheahan
Publikováno v:
European Journal of Surgical Oncology (EJSO). 42:1680-1686
Up to 15% of colorectal cancers exhibit microsatellite instability (MSI), where errors in replication go unchecked due to defects in the mismatch repair system. This study aimed to determine survival in a large single-centre series of 1250 consecutiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39d721531a79e895a57bb1215d005d1c
https://doi.org/10.1016/j.ejso.2016.05.013
https://doi.org/10.1016/j.ejso.2016.05.013
Autor:
É J, Ryan, B, Creavin, Y L, Khaw, M E, Kelly, H M, Mohan, R, Geraghty, E J, Ryan, R, Kennelly, A, Hanly, S T, Martin, D, Fennelly, R, McDermott, D, Gibbons, P R, O'Connell, K, Sheahan, D C, Winter
Publikováno v:
BJS Open
Background Caudal‐related homeobox transcription factor 2 (CDX2) is an intestine‐specific transcription factor implicated in tumour differentiation, proliferation, cell adhesion and migration. Negative CDX2 status (CDX2−) is associated with wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4fff4719b07014c1dbc06a4d66ce6cb
https://pubmed.ncbi.nlm.nih.gov/30511046
https://pubmed.ncbi.nlm.nih.gov/30511046
Autor:
A.M. Lennon, H.E. Mulcahy, J.M.P. Hyland, C. Lowry, A. White, D. Fennelly, J.J. Murphy, D.P. O’Donoghue, K. Sheahan
Publikováno v:
American Journal of Clinical Pathology. 119:108-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::432719830209f41916e929e076817235
https://doi.org/10.1309/j6bdtwm2m792tn2v
https://doi.org/10.1309/j6bdtwm2m792tn2v
Publikováno v:
European Journal of Surgical Oncology (EJSO). 35:444-446
Bevacizumab (Avastin , Genentech, Inc.) is a humanised monoclonal antibody directed against Vascular Endothelial Growth Factor (VEGF). Developed by Napoleone Ferrara and colleagues, it was the first commercially available antiangiogenesis therapy to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc0f543a68d12c2d3dc8c02c1fd1c70
https://doi.org/10.1016/j.ejso.2008.02.013
https://doi.org/10.1016/j.ejso.2008.02.013
Autor:
William J. Hoskins, Paul Sabbatini, Amreen Husain, M. Markman, Richard R. Barakat, Carol Aghajanian, John P. Curtin, D. Fennelly, David R. Spriggs, Ennapadam Venkatraman
Publikováno v:
Gynecologic Oncology. 73:96-101
Objective. The aim of this study was to determine the feasibility and efficacy of intraperitoneal cisplatin and mitoxantrone in patients with very small-volume residual disease at second-look surgery after completion of primary platinum-based intrave
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d68e70025b454861189efcf847b2983
https://doi.org/10.1006/gyno.1998.5317
https://doi.org/10.1006/gyno.1998.5317
Publikováno v:
Annals of Oncology. 27:vi226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::931288cde7f8c90bffd9264d181a70a6
https://doi.org/10.1093/annonc/mdw371.58
https://doi.org/10.1093/annonc/mdw371.58
Publikováno v:
Irish medical journal. 105(5)
We present the case of a 58-year old female with de novo dialysis-dependent acute kidney injury (AKI) secondary to myeloma cast nephropathy. The patient underwent extended high cut-off haemodialysis (HCO-HD), in conjunction with bortezomib-based chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe0fdf5c96489838003a3c475bd5fb40
https://pubmed.ncbi.nlm.nih.gov/22803494
https://pubmed.ncbi.nlm.nih.gov/22803494
Publikováno v:
European journal of cancer care. 21(6)
Peripheral neuropathy is the principal dose-limiting side effect of chemotherapy with oxaliplatin. Early biomarkers of oxaliplatin-related neuropathy (ON) are important for guiding management and as outcomes for neuroprotective trials. We compared a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03144c5f3e23672b6f8fed016dc98243
https://pubmed.ncbi.nlm.nih.gov/22594346
https://pubmed.ncbi.nlm.nih.gov/22594346